PhRMA chief dings health insurers over drug prices at their own conference
PhRMA’s Steve Ubl used an in-person health insurance industry conference to blame insurers for making people pay too much for drugs.
PhRMA’s Steve Ubl used an in-person health insurance industry conference to blame insurers for making people pay too much for drugs.
New CMS rule requires home-based care providers use 80 percent of their Medicaid reimbursements toward compensation for their workers.
Vivien Dugan, director of the flu division at the CDC, is helping to lead the national response to the H5N1 bird flu outbreak in cows.
Safely integrating AI into the clinical workflow could help address some of the limitations of human cognition when it comes to diagnosing medical problems.
Engaging people with bipolar disorder and translating their experiences into scientific research will help move from hope to real improvements in treatment.
Walmart had grand ambitions, back in 2019, to grow a network of cheaper primary care clinics attached to its ubiquitous stores. Those ambitions are now…
This week on “The Readout LOUD” podcast: controversial brain tissue research, obesity drug sales, and Novartis’ M&A drama.
Members of Congress appear likely to opt for a short-term extension of Medicare telehealth policies instead of permanent changes.
Amgen said that it will no longer develop an early-stage obesity pill, and will instead focus on an injectable candidate that’s seen as a potential…
Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to…
The move by the California Supreme Court to review the case is seen as “very important,” according Evercore ISI analyst Umer Raffat.